Teeselink, Sjan http://orcid.org/0000-0003-1023-2182
Vincenten, Sanne C. C. http://orcid.org/0000-0002-0412-0670
Voermans, Nicol C. http://orcid.org/0000-0002-5837-7295
Groothuis, Jan T. http://orcid.org/0000-0003-3436-2475
Doorduin, Jonne http://orcid.org/0000-0002-4157-1649
Wijkstra, Peter J. http://orcid.org/0000-0002-3809-5725
Horlings, Corinne G. C. http://orcid.org/0000-0002-2440-9180
van Engelen, Baziel G. M. http://orcid.org/0000-0001-9867-9047
Mul, Karlien http://orcid.org/0000-0001-8487-9478
Funding for this research was provided by:
Prinses Beatrix Spierfonds (W.OR12-22, W.OR18-07)
Article History
Received: 15 December 2021
Revised: 20 January 2022
Accepted: 22 January 2022
First Online: 11 February 2022
Declarations
:
: ST, SV, CH, JD, PW, KM and NV have no relevant financial or non-financial interests to disclose. JG reports grants from Prinses Beatrix Spierfonds and Fulcrum Therapeutics. BvE reports grants from Prinses Beatrix Spierfonds, Dutch FSHD Foundation and charitable foundation Spieren voor Spieren and consultancy for Fulcrum Therapeutics, Facio Therapies and Arrowhead Pharmaceuticals.
: This study was performed in accordance with the Medical Research Involving Human Subjects Act (WMO) and with the 1964 Helsinki Declaration and its later amendments. The protocol was approved by the Regional Medical Ethics Committee (CMO region Arnhem-Nijmegen). All patients signed informed consent.